Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics

Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics

kidneycancer

1 year
119 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Daniel Goldstein MD Tel Aviv University discusses Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia
Up Next Autoplay